Cargando…

Image-guidedcryoablation in unresectable or recurrent advanced colorectal cancer: a retrospective study

Purpose: The present study retrospectively analyzed thesafety and efficacy of computed tomography (CT)-guided cryoablationin the treatment ofunresectable or recurrent advanced colorectal cancer, which did not respond well to or experienced progression with radiotherapy or chemotherapy. Materials and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Guang-Zhi, He, Xin-Hong, Wang, Ying, Xu, Li-Chao, Huang, Hao-Zhe, Li, Guo-Dong, Wang, Yao-Hui, Li, Wen-Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shanghai Journal of Interventional Radiology Press 2019
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586567/ https://www.ncbi.nlm.nih.gov/pubmed/34805836 http://dx.doi.org/10.19779/j.cnki.2096-3602.2018.02.06

Ejemplares similares

CT-guided cryoablation for unresectable pelvic recurrent colorectal cancer: a retrospective study
por: Wang, Ying, et al.
Publicado: (2019)

Clinical Outcomes and Predictors in Patients With Unresectable Colorectal Cancer Liver Metastases Following Salvage Percutaneous Radiofrequency Ablation: A Single Center Preliminary Experience
por: Wang, Ying, et al.
Publicado: (2020)

Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer
por: Mochiki, E, et al.
Publicado: (2006)

Induction Chemotherapy in Technically Unresectable Locally Advanced Carcinoma of Maxillary Sinus
por: Noronha, Vanita, et al.
Publicado: (2014)

Retrospective analysis of transarterial chemoembolization and sorafenib in Chinese patients with unresectable and recurrent hepatocellular carcinoma
por: Wan, Xuying, et al.
Publicado: (2016)

Neoadjuvant chemotherapy in technically unresectable head and neck cancers: a retrospective audit
por: Mishra, Bal Krishna, et al.
Publicado: (2022)

Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study
por: Mosconi, Cristina, et al.
Publicado: (2016)

Adenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis
por: Hur, H, et al.
Publicado: (2012)

Validation and evaluation of clinical prediction systems for first and repeated transarterial chemoembolization in unresectable hepatocellular carcinoma: A Chinese multicenter retrospective study
por: Wang, Zhe-Xuan, et al.
Publicado: (2020)

Efficacy of the New Double-Layer Stent for Unresectable Distal Malignant Biliary Obstruction: A Single-Center Retrospective Study
por: Ito, Ken, et al.
Publicado: (2012)

A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei
por: Farquharson, A L, et al.
Publicado: (2008)

Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases
por: Barone, C, et al.
Publicado: (2007)

Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases
por: Cosimelli, M, et al.
Publicado: (2010)

A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer
por: Lee, J-L, et al.
Publicado: (2008)

Concurrent Imatinib and Radiation Therapy for Unresectable and Symptomatic Desmoid Tumors
por: Moding, Everett J., et al.
Publicado: (2017)

Phase II Study of Temozolomide and Thalidomide in Patients with Unresectable or Metastatic Leiomyosarcoma
por: Boyar, Michelle S., et al.
Publicado: (2008)

Retrospective Analysis of Cushing's Disease with or without Hyperprolactinemia
por: Huan, Cheng, et al.
Publicado: (2014)

Retrospective efficacy analysis of olaparib combined with bevacizumab in the treatment of advanced colorectal cancer
por: Jiang, Yi-Ling, et al.
Publicado: (2023)

Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer
por: Yokota, Tomoya, et al.
Publicado: (2016)

Efficacy and safety of anlotinib in patients with unresectable or metastatic bone sarcoma: A retrospective multiple institution study
por: Liu, Zhiyong, et al.
Publicado: (2021)

Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers
por: Kim, Chang Gon, et al.
Publicado: (2016)

Correlation between immune-related adverse events and long-term outcomes in pembrolizumab-treated patients with unresectable hepatocellular carcinoma: A retrospective study
por: Zhou, Jiang-Min, et al.
Publicado: (2023)

Retrospective Comparative Study of the Effects of Dendritic Cell Vaccine and Cytokine-Induced Killer Cell Immunotherapy with that of Chemotherapy Alone and in Combination for Colorectal Cancer
por: Niu, Jingxiu, et al.
Publicado: (2014)

Risk factors for thromboembolism during first-line treatment of patients with unresectable advanced or recurrent colorectal cancer: a retrospective short study
por: Takada, Ryo, et al.
Publicado: (2023)

Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer
por: Lee, S-H, et al.
Publicado: (2004)

Outcome of the Pediatric Patients with Portal Cavernoma: The Retrospective Study for 10 Years Focusing on Recurrent Variceal Bleeding
por: Guo, Hongjie, et al.
Publicado: (2016)

Recurrence of Retinopathy of Prematurity in Zone II Stage 3+ after Ranibizumab Treatment: A Retrospective Study
por: Hu, Qinrui, et al.
Publicado: (2017)

Outcomes of Microendoscopic Discectomy and Percutaneous Transforaminal Endoscopic Discectomy for the Treatment of Lumbar Disc Herniation: A Comparative Retrospective Study
por: Sinkemani, Arjun, et al.
Publicado: (2015)

Preoperative Mean Platelet Volume and Platelet Distribution Width Predict Postoperative Sepsis in Patients with Colorectal Cancer
por: Li, Xue-ting, et al.
Publicado: (2019)

Immune Response, Safety, and Survival and Quality of Life Outcomes for Advanced Colorectal Cancer Patients Treated with Dendritic Cell Vaccine and Cytokine-Induced Killer Cell Therapy
por: Zhu, Hui, et al.
Publicado: (2014)

Multicenter safety study of mFOLFOX6 for unresectable advanced/recurrent colorectal cancer in elderly patients
por: Sugimoto, Shinichi, et al.
Publicado: (2009)

Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma
por: Wang, Yan-Yu, et al.
Publicado: (2023)

Endovascular Treatment for Acute Thromboembolic Occlusion of the Superior Mesenteric Artery and the Outcome Comparison between Endovascular and Open Surgical Treatments: A Retrospective Study
por: Zhang, Zhao, et al.
Publicado: (2017)

Clinical efficacy and safety of nimotuzumab plus chemotherapy in patients with advanced colorectal cancer: a retrospective analysis
por: Bai, Sai-xi, et al.
Publicado: (2020)

Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
por: Takayama, T, et al.
Publicado: (2007)

Association between dialysis effluent leukocyte count after initial antibiotic treatment and outcomes of patients with peritoneal dialysis-associated peritonitis: a retrospective study
por: Hong, Tao, et al.
Publicado: (2023)

A prospective randomized comparative study to evaluate the effect of palliative hypo-fractionated radiotherapy with concurrent chemotherapy versus hypo-fractionated radiotherapy alone in advanced and unresectable head and neck cancer with no metastasis
por: Uttam, Aditya Kumar, et al.
Publicado: (2023)

Early detection of recurrence by (18)FDG-PET in the follow-up of patients with colorectal cancer
por: Sobhani, I, et al.
Publicado: (2008)

C3 glomerulonephritis associated with monoclonal gammopathy: a retrospective case series study from a single institute in China
por: Zhang, Xin, et al.
Publicado: (2021)

Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor
por: Shen, Chaoyong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_p1eu3ph39paf7a1vb3mu0236qt